ALVODRONIC 6 mg/6 ml Koncentrat za rastvor za infuziju Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

alvodronic 6 mg/6 ml koncentrat za rastvor za infuziju

alvogen d.o.o. barice - dio stranog druŠtva u podgorici - ibandronska kiselina - koncentrat za rastvor za infuziju - 6 mg/6 ml

PATAXEL 300mg/50ml Koncentrat za rastvor za infuziju Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

pataxel 300mg/50ml koncentrat za rastvor za infuziju

"osmi red-d" d.o.o. podgorica - paklitaksel - koncentrat za rastvor za infuziju - 300mg/50ml

PATAXEL 100mg/16.7ml Koncentrat za rastvor za infuziju Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

pataxel 100mg/16.7ml koncentrat za rastvor za infuziju

"osmi red-d" d.o.o. podgorica - paklitaksel - koncentrat za rastvor za infuziju - 100mg/16.7ml

Dupixent Unione Europea - croato - EMA (European Medicines Agency)

dupixent

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenti za dermatitis, isključujući kortikosteroide - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Cinqaero Unione Europea - croato - EMA (European Medicines Agency)

cinqaero

teva b.v. - reslizumab - astma - drugi sistemski lijekovi za opstruktivne plućne bolesti dišnih putova, - cinqaero je indiciran kao dodatna terapija u odraslih bolesnika s teškom astmom eozinofilni glikemija unatoč visokom dozom udahnuti kortikosteroidi plus još jedan lijek za terapiju održavanja.

Ondexxya Unione Europea - croato - EMA (European Medicines Agency)

ondexxya

astrazeneca ab - andexanet alfa - u svezi s drogom nuspojava i negativnih reakcija - svi ostali terapeutski proizvodi - za odrasle pacijente s izravnom faktora ha (fxa uspješno) inhibitor (апиксабан ili ривароксабан) otkaz kada antikoagulanse potreban zbog prijeteće života ili nekontroliranog krvarenja.

Ipigriks 15 mg/ml otopina za injekciju Croazia - croato - HALMED (Agencija za lijekove i medicinske proizvode)

ipigriks 15 mg/ml otopina za injekciju

grindeks as, krustpils iela 53, riga, latvija - ipidakrinklorid hidrat - otopina za injekciju - urbroj: jedna ampula s 1 ml otopine sadrži 15 mg ipidakrinklorida (u obliku hidrata)

Ipigriks 5 mg/ml otopina za injekciju Croazia - croato - HALMED (Agencija za lijekove i medicinske proizvode)

ipigriks 5 mg/ml otopina za injekciju

grindeks as, krustpils iela 53, riga, latvija - ipidakrinklorid hidrat - otopina za injekciju - urbroj: jedna ampula s 1 ml otopine sadrži 5 mg ipidakrinklorida (u obliku hidrata)